Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Julianne Hough Encourages Women to "Speak Up for Endo" during Endometriosis Awareness Month

      - Endometriosis affects an estimated one in 10 women of reproductive age, but diagnosis can take up to six to 10 years(1,2)

      - SpeakENDO offers information about endometriosis, true stories about women living with endometriosis and resources to help improve conversations with a healthcare professional

      - Women can share videos from SpeakENDO.com or post their own story on social media using #SpeakENDO


      News provided by

      AbbVie

      Mar 05, 2018, 08:00 ET

      Share this article

      Share this article


      NORTH CHICAGO, Ill., March 5, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research and development based global biopharmaceutical company, announced that actress, dancer and Emmy Award-winning choreographer Julianne Hough is encouraging women to discuss symptoms of endometriosis and advocate for their own care through a campaign called "SpeakENDO."  The campaign, sponsored by AbbVie, is for women who want to learn more about endometriosis, those trying to find out what may be causing their symptoms and women already diagnosed with endometriosis.

      AbbVie is partnering with Julianne Hough to SpeakENDO. Learn more at SpeakEndo.com.
      AbbVie is partnering with Julianne Hough to SpeakENDO. Learn more at SpeakEndo.com.
      Julianne Hough Speaks Endo
      Julianne Hough Speaks Endo
      AbbVie is partnering with Julianne Hough to SpeakENDO. Learn more at SpeakEndo.com.
      Julianne Hough Speaks Endo

      March is Endometriosis Awareness Month and women can visit SpeakENDO.com to learn how to "Speak Up for Endo" throughout the month.  Individuals can share an inspiring video to help increase disease recognition and awareness, learn about what makes endometriosis painful and help educate others, or post their own endometriosis story on social media with #SpeakENDO. Individuals can also sign up for SpeakENDO emails, tips, and resources.  A donation will be made to the Endometriosis Foundation of America for those who sign up.

      "I have endometriosis and for the past year, I've been speaking out to encourage women to 'get in the know' about endometriosis and raise awareness of this chronic and painful disease," said Hough, who is best known as a two-time professional champion and judge on Dancing with the Stars. "The painful symptoms associated with endometriosis can be hard to explain, but with proper knowledge and empowerment, women can start to 'speak endo' to their doctor, family members, boss and friends." 

      Endometriosis occurs when tissue that acts a lot like the lining of the uterus starts growing outside of the uterus, where it doesn't belong.3 Endometriosis is different for every woman and is associated with pain symptoms that can be debilitating and may interfere with day-to-day activities.4,5,6,7,8,9,10,11,12 SpeakENDO.com is a go-to resource for endometriosis and offers information and resources to help women share their story and get the most from a doctor's visit.

      "AbbVie is proud to continue to work with Julianne Hough to educate and help women fully express symptoms of endometriosis," said Michael Norton, vice president, head of U.S. medical affairs at AbbVie. "It's important for women to be specific about their endometriosis symptoms when speaking to a healthcare provider, which can be helpful in creating a treatment plan."

      About Endometriosis
      Endometriosis occurs when tissue that acts a lot like the lining of the uterus (endometrium) starts growing outside of your uterus, where it doesn't belong.3 These out-of-place growths, called lesions or implants, can cause severe pain and inflammation throughout the month.1,13,14 These growths are called lesions and can occur on the ovaries, the fallopian tubes, or other areas near the uterus, such as the bowel or bladder, leading to long-term pelvic pain (during or between periods), pain with intercourse and other painful symptoms. There is no cure for endometriosis,15,16 and the associated pain is currently managed with oral contraceptives, progestins, danazol, nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, and GnRH agonists, many of which are not specifically indicated for the treatment of endometriosis. In more extensive cases, surgical interventions (e.g., laparotomy or laparoscopy) are often pursued, and may not be curative for all individuals.

      About SpeakENDO
      SpeakENDO is a campaign for women who want to learn more about endometriosis, those trying to find out what may be causing their symptoms and women already diagnosed with endometriosis. The campaign offers the latest news and information about endometriosis, true stories about women living with endometriosis and resources to help women have a better conversation with their healthcare provider. Endometriosis is a chronic and painful disease that affects an estimated one in 10 women of reproductive age.1,2 Despite being one of the most common gynecologic disorders in America, there is a lack of awareness and prioritization of endometriosis as an important women's health issue.17 Learn more at SpeakENDO.com, and join the conversation online by sharing #SpeakENDO.

      About AbbVie
      AbbVie is a global, research and development-based biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world. For more information about AbbVie, please visit us at www.abbvie.com. Follow @AbbVieUS on Twitter, Facebook or LinkedIn.

      1 American College of Obstetricians and Gynecologists: Page 1, How Common is endometriosis? 
      2 Association of Professors of Gynecology and Obstetrics Endometriosis Guidelines Page 6, Col 2, Para 2, Lines 1-6
      3 APGO Endometriosis Guidelines Page 6, Col 2, Para 2, Lines 1-3
      4 ACOG 2010 Page 224, Col 1, Para 4, Lines 1-2
      5 ACOG FAQ 2012 Page 2, What are the symptoms of endometriosis, Lines 3-4 (heavy bleeding)
      6 Giudice 2010 Page 2390, Col 2, Para 1, Lines 1-12
      7 APGO Endometriosis Guidelines Page 8, Col 1, Para 4, Lines 3-4, Bullets 1-6; Col 2, Bullets 1-3
      8 Fourquet 2015 Page 11, Table 2
      9 Fourquet 2010 Page 3, Para 5, Lines 1-3; Page 4, Para 1, Lines 1-7; Para 4, Lines 1-6
      10 Fourquet 2011 Page 109, Col 1, Para 4, Lines 1-4, Col 2, Para 1, Line 1, Table 2, Table 3 calculations from Table 2: 14+19+57+43+24=157 (total number of patients asked if EM pain interferes with work) 19+57+43+24=143 (number of patients reporting EM pain interferes with work) 143/157 x 100 = 91%
      11 APGO Endometriosis Guidelines Page 6, Col 1, Para 1, Lines 1-6
      12 Youngwomenshealth.org Endometriosis Coping with Pain, Page 2, Para 2
      13 Liu merckmanual.com Page 3, Para 6, Line 1
      14 Bulun 2009 Page 268, Para 2, Lines 1-2; Lines 7-10
      15 Giudice 2012 Page 541, Col 1, Para 5, Line 2, Col 2, Para 1, Lines 1-4
      16 Womenshealth.gov Endometriosis Page 2, Para 2
      17 Missmer, S, Hankinson, S, Spiegelman, D, Barbieri, R, Marshall, L, Hunter, D. Incidence of Laparoscopically Confirmed Endometriosis by Demographic, Anthropometric, and Lifestyle Factors. American Journal of Epidemiology. 2004; 160 (8): 784-796.

      SOURCE AbbVie

      Modal title

      Also from this source

      AbbVie Reports Third-Quarter 2026 Financial Results

      AbbVie (NYSE:ABBV) announced financial results for the third quarter ended September 30, 2026. "AbbVie continues to deliver outstanding results,...

      The Countdown Is On: BOTOX® Cosmetic (onabotulinumtoxinA) Day is Back Nov. 18

      The Countdown Is On: BOTOX® Cosmetic (onabotulinumtoxinA) Day is Back Nov. 18

      Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the return of BOTOX® Cosmetic Day on Wednesday, Nov. 18, 2026. Now in its eighth ...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Pharmaceuticals

      Pharmaceuticals

      Biotechnology

      Biotechnology

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.